Atopic Dermatitis Research Study (1 Year)

Males and females 18 years of age and older, diagnosed with chronic atopic dermatitis (eczema) for at least 1 year, may qualify to participate in this research study. Participants must have moderate to severe eczema at the time of study entry.

Eligible participants will receive investigational study medication (active drug for 12 weeks, followed by active drug or placebo for the remainder of the study). Study medication will be provided at no cost. Reimbursement for study-related expenses will be provided.

Participation will last about 1 year and involve about 10 visits to the study center, as well as 2 telephone visits.

Call the study centre near you, or register now.

Learn more about
Atopic Dermatitis
Register Now!

Register for
Active Studies!


All information about you will be kept confidential.

If there are no active studies for your condition, we will keep your information and contact you when a new study starts in your area.

By registering you are consenting to the terms and conditions of our privacy policy.

Find the clinic near you:

Why Take Part In a Clinical Study?

Regulatory agencies like Health Canada, Australia's Therapeutic Goods Administration and the FDA require that Clinical Research Trials be conducted in order to develop new treatments, preventions and devices for diseases or conditions. Clinical Research Trials are also referred to as Clinical Studies or Clinical Trials. read more